<DOC>
	<DOC>NCT01103037</DOC>
	<brief_summary>This study will assess the safety and efficacy of QAV680 in patients with mild to moderate asthma</brief_summary>
	<brief_title>Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients with moderate persistent asthma Smokers Any significant disease or illness, other than asthma Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Mild</keyword>
	<keyword>Moderate</keyword>
	<keyword>Asthma</keyword>
</DOC>